Literature DB >> 15236834

Genes, proteins, and neurotoxins involved in Parkinson's disease.

O von Bohlen und Halbach1, A Schober, K Krieglstein.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder. The etiology of PD is likely due to combinations of environmental and genetic factors. In addition to the loss of neurons, including dopaminergic neurons in the substantia nigra pars compacta, a further morphologic hallmark of PD is the presence of Lewy bodies and Lewy neurites. The formation of these proteinaceous inclusions involves interaction of several proteins, including alpha-synuclein, synphilin-1, parkin and UCH-L1. Animal models allow to get insight into the mechanisms of several symptoms of PD, allow investigating new therapeutic strategies and, in addition, provide an indispensable tool for basic research. In animals PD does not arise spontaneously, thus, characteristic and specific functional changes have to be mimicked by application of neurotoxic agents or by genetic manipulations. In this review we will focus on genes and gene loci involved in PD, the functions of proteins involved in the formation of cytoplasmatic inclusions, their interactions, and their possible role in PD. In addition, we will review the current animal models of PD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236834     DOI: 10.1016/j.pneurobio.2004.05.002

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  45 in total

Review 1.  Neuroproteomics as a promising tool in Parkinson's disease research.

Authors:  Ilse S Pienaar; William M U Daniels; Jürgen Götz
Journal:  J Neural Transm (Vienna)       Date:  2008-06-04       Impact factor: 3.575

2.  Signaling with homeoprotein transcription factors in development and throughout adulthood.

Authors:  A Prochiantz
Journal:  Curr Genomics       Date:  2013-09       Impact factor: 2.236

Review 3.  Agrochemicals, α-synuclein, and Parkinson's disease.

Authors:  Blanca A Silva; Leonid Breydo; Anthony L Fink; Vladimir N Uversky
Journal:  Mol Neurobiol       Date:  2012-08-30       Impact factor: 5.590

Review 4.  Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.

Authors:  Blanca A Silva; Leonid Breydo; Vladimir N Uversky
Journal:  Mol Neurobiol       Date:  2012-09-01       Impact factor: 5.590

5.  PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.

Authors:  Dwayne Brown; Andrea Tamas; Dora Reglödi; Yousef Tizabi
Journal:  J Mol Neurosci       Date:  2013-04-28       Impact factor: 3.444

6.  The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat.

Authors:  Kobra Zare; Akram Eidi; Mehrdad Roghani; Ali Haeri Rohani
Journal:  Metab Brain Dis       Date:  2014-08-16       Impact factor: 3.584

7.  Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson's Disease.

Authors:  Kuo-Hsuan Chang; Mei-Ling Cheng; Hsiang-Yu Tang; Cheng-Yu Huang; Yih-Ru Wu; Chiung-Mei Chen
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

8.  Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat.

Authors:  Siamak Afshin-Majd; Mohsen Khalili; Mehrdad Roghani; Narges Mehranmehr; Tourandokht Baluchnejadmojarad
Journal:  Mol Neurobiol       Date:  2014-06-18       Impact factor: 5.590

9.  Evaluation of toxicological and antioxidant potential of Nardostachys jatamansi in reversing haloperidol-induced catalepsy in rats.

Authors:  A S Rasheed; S Venkataraman; K N Jayaveera; A Mohammed Fazil; K J Yasodha; M A Aleem; M Mohammed; Z Khaja; B Ushasri; H A Pradeep; M Ibrahim
Journal:  Int J Gen Med       Date:  2010-05-26

10.  Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.

Authors:  Ming Tong; Matthew Dong; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.